AbbVie Inc. News Headlines

ABBV 
$54.96
*  
0.83
1.49%
Get ABBV Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AbbVie Increases Bid For Shire To Indicative Value Of £51.15/Shr - Quick Facts
7/8/2014 8:04:00 AM - RTT News

AbbVie: Barclays Is Late To Upgrade, Using Highly Favorable Assumptions
7/3/2014 11:38:00 AM - Seeking Alpha

Gilead Seeks Japanese Approval for Sovaldi - Analyst Blog
6/30/2014 5:11:00 PM - Zacks.com

AbbVie's Oncology Candidate Progresses - Analyst Blog
6/30/2014 4:45:00 PM - Zacks.com

Consider Shire Pharmaceuticals Now; 20%+ Upside Left In Takeover Bid By AbbVie
6/30/2014 10:38:00 AM - Seeking Alpha

European Stocks Seen Inching Higher Ahead Of Data Deluge
6/30/2014 2:22:00 AM - RTT News

Notable ETF Outflow Detected - DLN, LLY, QCOM, ABBV
6/27/2014 11:13:31 AM - BNK Invest

AbbVie Now #45 Largest Company, Surpassing CVS
6/26/2014 4:39:50 PM - BNK Invest

Shire Snubs AbbVie Offer Again, Favorable Ruling for Vyvanse - Analyst Blog
6/26/2014 2:25:00 PM - Zacks.com

Gilead Will Continue Its Rise
6/26/2014 9:48:00 AM - Seeking Alpha

AbbVie Begins Phase III Trial Of Veliparib For Advanced Breast Cancer
6/26/2014 8:27:00 AM - RTT News

LONDON MARKETS: U.K. Stocks Fall As Part Of Global Equity Slump
6/25/2014 12:26:00 PM - Dow Jones Business News

Shire Leads Gains Among European ADRs After Abbvie Statement on Possible Takeover, U.S. Patent Ruling
6/25/2014 12:20:59 PM - MT Newswires

LONDON MARKETS: U.K. Stocks Pull Lower As Part Of Global Equity Slump
6/25/2014 9:10:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a possible offer -4-
6/25/2014 7:15:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a possible offer -3-
6/25/2014 7:15:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a possible offer -2-
6/25/2014 7:15:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a possible offer for Shire plc
6/25/2014 7:15:00 AM - Dow Jones Business News

Why Investors Should Sell AbbVie And Buy Gilead Sciences
6/24/2014 6:25:00 PM - Seeking Alpha

AbbVie Raises Outlook amidst Shire Takeover Attempts - Analyst Blog
6/24/2014 4:40:00 PM - Zacks.com

Abbott Labs to Buy Russia-Based Veropharm - Analyst Blog
6/24/2014 4:15:00 PM - Zacks.com

Abbott Laboratories: Recent Emerging Market Acquisitions Boost Growth Profile
6/24/2014 3:49:00 PM - Seeking Alpha

Syngenta Shares Rise On Report Of $40 Bln Takeover Approach By Monsanto
6/24/2014 7:22:00 AM - RTT News

Abbott to Acquire Russian Drug Maker Veropharm
6/23/2014 5:45:00 PM - Dow Jones Business News

Shire Rejects AbbVie's Offer, Shares Up - Analyst Blog
6/23/2014 5:31:00 PM - Zacks.com